JENNIFER PICKWELL: Open Payments
NPI 1265606107 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,716 in 94 payments from 30 companies in 2025. Trend: 2023 $1,369 · 2024 $2,406 · 2025 $2,716
Food & beverage: $1,835Long term medical supply or device loan: $881
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $1,058 |
| Celgene Corporation | 14 | $215 |
| ABBVIE INC. | 5 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $124 |
| Incyte Corporation | 4 | $110 |
| PFIZER INC. | 5 | $109 |
| EMD Serono, Inc. | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
Products named: KISQALI, REBLOZYL, EPKINLY, NINLARO, Nubeqa, LIBTAYO, PADCEV, MONJUVI.
Industry payments across TN — which companies pay providers there.
